WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search

QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL04 IMMUNOSUPPRESSANTS
QL04A IMMUNOSUPPRESSANTS
QL04AC Interleukin inhibitors
QL04AC01 daclizumab
QL04AC02 basiliximab
QL04AC03 anakinra
QL04AC04 rilonacept
QL04AC05 ustekinumab
QL04AC07 tocilizumab
QL04AC08 canakinumab
QL04AC09 briakinumab
QL04AC10 secukinumab
QL04AC11 siltuximab
QL04AC12 brodalumab
QL04AC13 ixekizumab
QL04AC14 sarilumab
QL04AC15 sirukumab
QL04AC16 guselkumab
QL04AC17 tildrakizumab
QL04AC18 risankizumab
QL04AC19 satralizumab
QL04AC20 netakimab
QL04AC21 bimekizumab
QL04AC22 spesolimab
QL04AC23 olokizumab
QL04AC24 mirikizumab
QL04AC25 levilimab

Last updated: 2024-01-17